期刊文献+

PT多肽修饰的地塞米松纳米脂质载体的体外释放研究 被引量:1

Study on the release characteristics of PT peptide grafted Dexamethasone nanostructured lipid carriers in vitro
原文传递
导出
摘要 目的研究PT多肽修饰的地塞米松纳米脂质载体的体外释放规律。方法选用pH7.4磷酸盐缓冲液作为释药介质,测定并绘制其体外释放曲线,并拟合释药数据。结果 PT多肽修饰的地塞米松纳米脂质载体在0.5 h的突释率为24.2%,24h药物累计释放量为88%,最佳拟合模型为Weibull方程。结论 PT多肽修饰的地塞米松纳米脂质载体的体外释放突释效应减少,具有缓释效应。 OBJECTIVE To study the release characteristics of PT peptide grafted dexamethasone nanostructured lipid carriers in vitro.METHODS Phosphate buffer(pH7.4) was chosen as the release medium.The characteristics of in vitro release were investigated and simulated by regression equation.RESULTS The initial release rate in 0.5 h and the accumulation release rate in 24 h of PT peptide grafted dexamethasone nanostructured lipid carriers in vitro were 24.2% and 88%,respectively.The data was best fitted with Weibull equation.CONCLUSION Sustained-release effect is the release characteristic of PT peptide grafted dexamethasone nanostructured lipid carriers in vitro,and its burst-release effect is declined.
出处 《华西药学杂志》 CAS CSCD 北大核心 2013年第1期71-72,共2页 West China Journal of Pharmaceutical Sciences
基金 深圳市科技计划资助项目(编号:201002046)
关键词 地塞米松 PT多肽修饰 纳米脂质载体 体外释放 Dexamethasone PT peptide Nanostructured lipid carriers Release characteristic
  • 相关文献

参考文献7

  • 1李光伟.警惕糖皮质激素治疗的副作用[J].中华内科杂志,2003,42(10):678-679. 被引量:20
  • 2Wang MT,Jin Y,Yang YX. In vivo biodistribution,anti-inflammatory,and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructrued lipid carriers systemp[J].Int J Nanomedi,.
  • 3XF Xu,CY Zhao,HY Yang. Anti-inflammatory activity of injectable dexamethasone acetate loaded nanostructrued lipid carriers[J].Drug Delivery,2011,(07):485-492.
  • 4CY Zhao,Y Liu,TT Fan. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration[J].Pharma Dev Techno1,2011.1-14.
  • 5Gaete CG,Tsapis N,Besnard M. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles[J].International Journal of Pharmaceutics,2007.153-159.
  • 6Wei W,Shi SJ,Liu J. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application[J].Journal of Drug Targeting,2010,(7):557-566.
  • 7Aviral Jain,Gousia Chasoo,Shashank KS. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain:In vitro characterization[J].Journal of Microencapsulation,2011,(01):21-28.

共引文献19

同被引文献12

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部